Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus‐1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub‐study A5334s

AIMS: AIDS Clinical Trials Group study A5334s evaluated the pharmacokinetics of raltegravir before and during combined administration of ombitasvir, paritaprevir/ritonavir, plus dasabuvir (OBV/PTV/r + DSV) and weight‐based ribavirin in human immunodeficiency virus (HIV) and hepatitis C virus (HCV) c...

詳細記述

保存先:
書誌詳細
出版年:Br J Clin Pharmacol
主要な著者: Venuto, Charles S., Cramer, Yoninah S., Rosenkranz, Susan L., Sulkowski, Mark, Wyles, David L., Cohen, Daniel E., Schmidt, Jeffrey, Alston‐Smith, Beverly L., Morse, Gene D.
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2019
主題:
Original Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6983509/
https://ncbi.nlm.nih.gov/pubmed/31656054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14148
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料